UroGen Pharma Ltd. (URGN)
URGN price $35.48 +0.47 +1.36%
- Ticker
- URGN
- Price
- $35.48
- Change
- +0.47 +1.36%
- Market cap
- $1.73B
- P/E
- -17.68
- Forward P/E
- 12.46
- Sector
- Healthcare
- Industry
- Biotechnology
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers. It offers RTGel, a novel proprietary polymeric biocompatible, reverse thermal gelation hydrogel technology; Mitomycin a generic drug used off-label as an adjuvant chemotherapy for the treatment of low-grade NMIBC after trans-urethral resection of bladder tumor; Zusduri, a…